References
- Clish CB. Metabolomics: an emerging but powerful tool for precision medicine. Cold Spring Harb Mol Case Stud. 2015;1:a000588.
https://doi.org/10.1101%2Fmcs.a000588 . - Bikle DD. Vitamin D: Production, Metabolism and Mechanisms of Action. [Updated 2021 Dec 31]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK278935/ - Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59:881–6.
https://doi.org/10.231%2FJIM.0b013e31821b8755 . - Grover S, Dougan M, Tyan K, Giobbie-Hurder A, Blum SM, Ishizuka J, Qazi T, Elias R, Vora KB, Ruan AB, Martin-Doyle W, Manos M, Eastman L, Davis M, Gargano M, Haq R, Buchbinder EI, Sullivan RJ, Ott PA, Hodi FS, Rahma OE. Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis. Cancer. 2020 Aug 15;126(16):3758–3767. doi: 10.1002/cncr.32966. Epub 2020 Jun 22. PMID: 32567084; PMCID: PMC7381363.
- Bersanelli M, Cortellini A, Leonetti A, Parisi A, Tiseo M, Bordi P, Michiara M, Bui S, Cosenza A, Ferri L, Giudice GC, Testi I, Rapacchi E, Camisa R, Vincenzi B, Caruso G, Rauti AN, Arturi F, Tucci M, Santo V, Ricozzi V, Burtet V, Sgargi P, Todeschini R, Zustovich F, Stucci LS, Santini D, Buti S. Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study. Cancer Immunol Immunother. 2023 Nov;72(11):3707–3716. doi: 10.1007/s00262-023-03522-3. Epub 2023 Aug 28. PMID: 37638980; PMCID: PMC10576732.
- Yuan R, Zhang W, You YP, Cui G, Gao Z, Wang X, Chen J. Vitamin D3 suppresses the cholesterol homeostasis pathway in patient-derived glioma cell lines. FEBS Open Bio. 2023 Sep;13(9):1789–1806. doi: 10.1002/2211-5463.13679. Epub 2023 Jul 31. PMID: 37489660; PMCID: PMC10476568.
- Lo CS, Kiang KM, Leung GK. Anti-tumor effects of vitamin D in glioblastoma: mechanism and therapeutic implications. Lab Invest. 2022 Feb;102(2):118–125. doi: 10.1038/s41374-021-00673-8. Epub 2021 Sep 9. PMID: 34504307.
- Morelli M, Di Lorenzo F, Nannipieri F, Trasciatti S, Di Stefano A, Lessi F, Mazzanti C. P26.14.B vitamin D3 enhances temozolomide efficacy in glioblastoma cells while protecting normal astrocytes: investigating the effects of adjunctive therapy. Neuro-Oncol. 2024; 26(5):136,
https://doi.org/10.1093/neuonc/noae144.462 - France MA, Larrea L, Deppiagio M, Duque R, Vasquez G, Markos Oset M, Cardenal R, Tormo. Ferrero V, Amr O. Vitamin D Levels in Blood and Survival in Glioblastoma. 2017. 92(2):
- Salomón DG, Fermento ME, Gandini NA, Ferronato MJ, Arévalo J, Blasco J, Andrés NC, Zenklusen JC, Curino AC, Facchinetti MM. Vitamin D receptor expression is associated with improved overall survival in human glioblastoma multiforme. J Neurooncol. 2014 May;118(1):49–60. doi: 10.1007/s11060-014-1416-3. Epub 2014 Mar 1. PMID: 24584679.
- Elmaci I, Ozpinar A, Ozpinar A, Perez JL, Altinoz MA. From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D + all-trans retinoic acid + Temozolomide combination in treatment of GBM. Metab Brain Dis. 2019;34:687–704.
https://doi.org/10.1007/s11011-019-00412-5 . - Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842–856.
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281.
- Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303:1815–1822.
- Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6:847–858.
- Kramer H, Sempos C, Cao G, Luke A, Shoham D, Cooper R, Durazo-Arvizu R. Mortality rates across 25-hydroxyvitamin D (25[OH]D) levels among adults with and without estimated glomerular filtration rate <60 ml/min/1.73 m2: the third national health and nutrition examination survey. PLoS One. 2012;7:e47458.